Dannce.ai emerged from stealth with a platform that aims to use artificial intelligence to help diagnose and monitor movement ...

The test is part of Toyota's "multi-pathway strategy," through which the automaker aims to provide a range of green vehicles, including gasoline-electric hybrids, hydrogen-powered fuel cells and ...

The test is part of Toyota's "multi-pathway strategy," through which the automaker aims to provide a range of green vehicles, including gasoline-electric hybrids, hydrogen-powered fuel cells and ...

Tardive dyskinesia is not typically reversible, but on rare occasions, it can be if caught early and treated immediately. Tardive dyskinesia (TD) is a medication-induced movement disorder ...

Did You Know Tardive Dyskinesia Could Be a Side Effect of Bipolar Medications? Managing both bipolar disorder and tardive dyskinesia can feel overwhelming. Antipsychotic medications, which are often ...

If you’re living with tardive dyskinesia (TD), you already know its effects on your body. The involuntary movements in your face, limbs, and torso can make it hard to do everyday activities ...

Whether someone you know already has tardive dyskinesia (TD) or they're at risk for it because of a medicine they take, you might wonder how you can help. People who have this movement disorder ...

An experimental portable device might be able to detect lung cancer from a person's exhaled breath, researchers report. The device contains "nanoflake" sensors that can detect small changes in the ...

US neuroscience-focused biopharma Neurocrine Biosciences (Nasdaq: NBIX) presented new data from more than 300 patients diagnosed with tardive dyskinesia and treated with Ingrezza (valbenazine) ...

"I saw that it had potential and it should be good for nature, good for the climate. And I thought it was worth testing my wild ideas — that's where it started," Alness said in the story.

(NASDAQ:NBIX) revealed study results indicating that nearly 60% of participants achieved remission of tardive dyskinesia after ... Involuntary Movement Scale (AIMS) score, which assesses the ...

Levodopa-induced dyskinesia (LID) is a common complication after dopamine-replacement therapy in Parkinson's disease. The neural mechanisms underlying LID are far from clear, although significant ...